A remembrance: James B. Nachman 1948-2011.

about

A remembrance: James B. Nachman 1948-2011.

Item

http://www.wikidata.org/entity/Q46189930

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

A remembrance: James B. Nachman 1948-2011.

@en

A remembrance: James B. Nachman 1948-2011.

@nl

type

Item

label

A remembrance: James B. Nachman 1948-2011.

@en

A remembrance: James B. Nachman 1948-2011.

@nl

prefLabel

A remembrance: James B. Nachman 1948-2011.

@en

A remembrance: James B. Nachman 1948-2011.

@nl

P1476

A remembrance: James B. Nachman 1948-2011.

@en

P2860

A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6-7 May 2009.

Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.

P304

533-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.23276

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul S. Gaynon

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21826779

http://www.w3.org/2001/XMLSchema#string